BIONTECH Profit Margin vs. Price To Earnings To Growth
| B1NT34 Stock | BRL 44.53 0.49 1.09% |
For BIONTECH profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BIONTECH to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BIONTECH SE DRN utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BIONTECH's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BIONTECH SE DRN over time as well as its relative position and ranking within its peers.
BIONTECH |
BIONTECH SE DRN Price To Earnings To Growth vs. Profit Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BIONTECH's current stock value. Our valuation model uses many indicators to compare BIONTECH value to that of its competitors to determine the firm's financial worth. BIONTECH SE DRN is number one stock in profit margin category among its peers. It also is number one stock in price to earnings to growth category among its peers producing about 0.01 of Price To Earnings To Growth per Profit Margin. The ratio of Profit Margin to Price To Earnings To Growth for BIONTECH SE DRN is roughly 99.29 . Comparative valuation analysis is a catch-all model that can be used if you cannot value BIONTECH by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BIONTECH's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BIONTECH Price To Earnings To Growth vs. Profit Margin
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
BIONTECH |
| = | 0.56 % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
BIONTECH |
| = | 0.01 X |
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
BIONTECH Price To Earnings To Growth Comparison
BIONTECH is currently under evaluation in price to earnings to growth category among its peers.
BIONTECH Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BIONTECH. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BIONTECH position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BIONTECH's important profitability drivers and their relationship over time.
Use BIONTECH in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BIONTECH position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIONTECH will appreciate offsetting losses from the drop in the long position's value.BIONTECH Pair Trading
BIONTECH SE DRN Pair Trading Analysis
The ability to find closely correlated positions to BIONTECH could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BIONTECH when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BIONTECH - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BIONTECH SE DRN to buy it.
The correlation of BIONTECH is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BIONTECH moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BIONTECH SE DRN moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BIONTECH can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BIONTECH position
In addition to having BIONTECH in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Food Products Thematic Idea Now
Food Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Food Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Food Products Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BIONTECH Stock
To fully project BIONTECH's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BIONTECH SE DRN at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BIONTECH's income statement, its balance sheet, and the statement of cash flows.